Company profile for Vapogenix

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Vapogenix is a clinical stage company developing a new class of topical, non-opioid analgesics to alleviate pain. While most pain is localized, most pain medications are administered orally, which often results in systemic side effects. We are focused on treating pain locally – at its source. Our products are volatile anesthetics formulated for topical application; currently unformulated volatile anesthetics are approved for...
Vapogenix is a clinical stage company developing a new class of topical, non-opioid analgesics to alleviate pain. While most pain is localized, most pain medications are administered orally, which often results in systemic side effects. We are focused on treating pain locally – at its source. Our products are volatile anesthetics formulated for topical application; currently unformulated volatile anesthetics are approved for use only as general anesthetics. Our lead product is a topical analgesic, has recently completed a Phase II clinical trial for treating wound pain.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
8285 El Rio St., Suite 170 Houston, TX 77054
Telephone
Telephone
713-748-3903
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.biospace.com/article/releases/vapogenix-awarded-1-5m-phase-ii-sbir-grant-to-develop-groundbreaking-topical-therapy-for-painful-inflammatory-conditions/

BIOSPACE
11 Nov 2020

https://www.biospace.com/article/releases/apogenix-to-start-european-clinical-phase-ii-trial-with-asunercept-in-covid-19-patients/

BIOSPACE
28 Jul 2020

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty